Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2024 Election Summary, Outlook for the Lame Duck Session & the New Congress

From the College  |  November 12, 2024

The ACR’s top priority before the end of the year is to have Congress address the additional 2.83% cut to physicians in the final physician fee schedule for 2025. Since 2001, doctors have seen a cumulative pay cut of 29%, according to the AMA. These cuts come on top of the increasing costs of operating a practice, which went up 39% due to inflation. Congress must act before the end of the year to avoid the additional cuts and to have physician reimbursements updated to reflect inflationary pressures, the same way all other Medicare schedules are.

Another ACR priority for the lame duck is extending telemedicine flexibilities. One silver lining from the COVID-19 pandemic was expanded use of telemedicine. It is estimated that 74% of practices now provide telemedicine services, but without action from Congress, Medicare will go back to the far more restrictive use of these services seen before the pandemic. Although telemedicine is not a replacement for essential face-to-face assessments, nearly five years since the start of the pandemic, more and more patients are coming to rely on the flexibility and ease of telehealth services.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Unfortunately, the election results will make these priorities less likely than before as the House majority will be inclined to hold off on legislating until 2025, when they have a majority in the Senate and a friendlier White House to work with. For most of our priorities, this means starting over by reintroducing bills in the new Congress. Medicare reimbursement and telemedicine, however, have important deadlines at the end of 2024, so this Congress must act before the year ends.

Checks & Balances

Starting in 2025, there will be new rules as well as a new administration. For the last 40 years, agencies have interpreted statutes and promulgated rules knowing that they would be given deference by the courts known as “Chevron deference.” The Supreme Court’s decision in Loper Bright Enterprises v. Raimondo changed that. The Loper decision holds that courts must “exercise independent judgment in determining the meaning of statutory provisions” and may not defer to an agency’s interpretation of an ambiguous statute. This is a substantial curtailment of the authority of the executive branch. Because courts will assume a broader role in interpreting ambiguous statutes, it is reasonable to expect that the next administration will have to deal with a potentially unprecedented number of legal challenges to rule changes and statutory interpretation that could stall and delay policy changes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:federal administrationfederal policy

Related Articles

    After the 2020 Election, What’s in Store for Rheumatology Advocacy?

    November 22, 2020

    Despite high voter turnout and many new faces entering Congress, minimal power shifts in most levels of government will have implications for the ACR’s advocacy agenda in 2021.

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Healthcare Policy Prospects in the 118th Congress

    February 4, 2023

    The U.S. government remains divided. Democrats hold the White House and the Senate by one vote, and Republicans lead the House. Amid this division, the ACR is watching possible areas to advance healthcare legislation. Meet the committees and members with the largest jurisdiction over healthcare policy.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences